Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 E 2nd St
Richland Center, WI 53581Phone+1 608-647-6321Fax+1 608-647-8940- Is this information wrong?
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2005 - 2007
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2003 - 2005
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2000 - 2003
- Indiana University School of MedicineClass of 2000
Certifications & Licensure
- WI State Medical License 2001 - 2025
- IL State Medical License 2007 - 2011
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
- Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL Start of enrollment: 2009 Oct 01
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia Start of enrollment: 2011 Apr 27
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsEBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.Agrawal, P., David, K., Chen, Z., Sundaram, S., Kim, S., Vaca, R., Lin, Y., Singer, S., Malecek, M., Carter, J., Zayac, A., Kim, M., Reddy, N., Ney, D., Habib, A., Str...> ;Leukemia & Lymphoma. 2023 May 1
- 14 citationsPembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study.Gregory, G., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F., Klein,...> ;Blood Advances. 2022 Feb 22
- 79 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.Andrew D. Zelenetz, Leo I. Gordon, Julie E. Chang, Beth Christian, Jeremy S. Abramson, Ranjana H. Advani, Nancy L. Bartlett, L. Elizabeth Budde, Paolo Caimi, Sven de V...> ;Journal of the National Comprehensive Cancer Network. 2021 Nov 1
- Join now to see all
Press Mentions
- Will Maintenance Lenalidomide Become A Standard for Relapsed CLL?November 2nd, 2017
- Wisconsin Cancer Patients Test Encouraging Lymphoma TreatmentDecember 23rd, 2016
Professional Memberships
- Member
Hospital Affiliations
- University HospitalMadison, Wisconsin
- Richland HospitalRichland Center, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: